Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Arun

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
The Oncologist|November 25, 2004
Ductal lavage and risk assessment of breast cancerBanu Arun
Journal of the National Comprehensive Cancer Network : JNCCN|October 3, 2009
Management of women at high risk for breast cancerBanu Arun
Journal of the National Comprehensive Cancer Network : JNCCN|October 26, 2010
Clinical assessment of breast cancer risk based on family historyKaylene Ready, Banu Arun
Breast (Edinburgh, Scotland)|December 9, 2016
BRCA mutation genetic testing implications in the United StatesSoley Bayraktar, Banu Arun
Seminars in Oncology|June 5, 2004
The role of COX-2 inhibition in breast cancer treatment and preventionBanu Arun, Paul Goss
The Breast Journal|May 16, 2012
Dose-dense chemotherapy for breast cancerSoley Bayraktar, Banu Arun
Cancer Journal (Sudbury, Mass.)|January 21, 2021
PARP Inhibitors in Triple-Negative Breast Cancer Including Those With BRCA MutationsRachel M Layman, Banu Arun
Current Oncology Reports|March 18, 2022
Helping Patients Understand and Cope with BRCA MutationsSukh Makhnoon, Banu Arun, Isabelle Bedrosian
Expert Opinion on Pharmacotherapy|May 31, 2002
The search for the ideal SERMBanu Arun, Marietta Anthony, Barbara Dunn
Statistics in Medicine|December 20, 2013
Reclassification of predictions for uncovering subgroup specific improvementSwati Biswas, Banu Arun, Giovanni Parmigiani
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
The Oncologist|November 25, 2004
Ductal lavage and risk assessment of breast cancerBanu Arun
Journal of the National Comprehensive Cancer Network : JNCCN|October 3, 2009
Management of women at high risk for breast cancerBanu Arun
Journal of the National Comprehensive Cancer Network : JNCCN|October 26, 2010
Clinical assessment of breast cancer risk based on family historyKaylene Ready, Banu Arun
Breast (Edinburgh, Scotland)|December 9, 2016
BRCA mutation genetic testing implications in the United StatesSoley Bayraktar, Banu Arun
Seminars in Oncology|June 5, 2004
The role of COX-2 inhibition in breast cancer treatment and preventionBanu Arun, Paul Goss
The Breast Journal|May 16, 2012
Dose-dense chemotherapy for breast cancerSoley Bayraktar, Banu Arun
Cancer Journal (Sudbury, Mass.)|January 21, 2021
PARP Inhibitors in Triple-Negative Breast Cancer Including Those With BRCA MutationsRachel M Layman, Banu Arun
Current Oncology Reports|March 18, 2022
Helping Patients Understand and Cope with BRCA MutationsSukh Makhnoon, Banu Arun, Isabelle Bedrosian
Expert Opinion on Pharmacotherapy|May 31, 2002
The search for the ideal SERMBanu Arun, Marietta Anthony, Barbara Dunn
Statistics in Medicine|December 20, 2013
Reclassification of predictions for uncovering subgroup specific improvementSwati Biswas, Banu Arun, Giovanni Parmigiani
Pageof 18